On the immunomodulating effects of anti-cancer drugs and their therapeutic exploitation

被引：10
|
作者：
Mihich, E [1 ]
机构：
[1] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
来源：
JAPANESE JOURNAL OF CLINICAL ONCOLOGY | 2000年 / 30卷 / 11期
关键词：
D O I：
10.1093/jjco/hyd127
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：469 / 471
页数：3
相关论文
共 50 条
  • [1] Novel anti-cancer drugs and therapeutic approaches
    Bergmann-Leitner, E
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (03) : 259 - 260
  • [2] Immunomodulating tellurium compounds as anti-cancer agents
    Sredni, Benjamin
    SEMINARS IN CANCER BIOLOGY, 2012, 22 (01) : 60 - 69
  • [3] Anti-cancer drugs
    Bergmann-Leitner, ES
    CURRENT PHARMACEUTICAL DESIGN, 2005, 11 (09) : 1077 - 1078
  • [4] Anti-cancer drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2008, 14 (11) : 1048 - 1048
  • [5] Anti-Cancer Drugs
    Bergmann-Leitner, Elke
    CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (07) : 730 - 731
  • [6] Clinical relevance of therapeutic benefit in anti-cancer drugs assessment
    Zysk, Rafal
    Krzakowski, Maciej
    Jassem, Jacek
    Krzemieniecki, Krzysztof
    Potemski, Piotr
    Wysocki, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2015, 11 (01): : 1 - 8
  • [7] Anti-Cancer immunotherapy: Immunomodulating agents in clinical development
    Loirat, D.
    Le Tourneau, C.
    ONCOLOGIE, 2015, 17 (09) : 379 - 389
  • [8] ENDOCRINE SIDE EFFECTS OF ANTI-CANCER DRUGS Effects of anti-cancer targeted therapies on lipid and glucose metabolism
    Verges, Bruno
    Walter, Thomas
    Cariou, Bertrand
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2014, 170 (02) : R43 - R55
  • [9] Supramolecular photonic therapeutic agents: pH Responsive anti-cancer drugs
    O'Shea, DF
    McDonnell, S
    Hall, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2507 - U2508
  • [10] Teratogens as anti-cancer drugs
    Blagosklonny, MV
    CELL CYCLE, 2005, 4 (11) : 1518 - 1521
12345